Full-Time

Senior FP&a Analyst

Confirmed live in the last 24 hours

ArsenalBio

ArsenalBio

201-500 employees

Develops programmable cell therapies for cancer

Biotechnology
Healthcare

Compensation Overview

$110.2k - $135kAnnually

Senior

San Bruno, CA, USA

Work onsite based in our South San Francisco office.

Category
Financial Planning and Analysis (FP&A)
Finance & Banking
Required Skills
Data Analysis
PowerPoint/Keynote/Slides
Requirements
  • Bachelor’s degree in Accounting or Finance with strong understanding of Generally Accepted Accounting Principles (GAAP)
  • 5+ years experience in FP&A and/or banking, or similar analytics experience, biotech industry experience a plus
  • Demonstrated attention to detail and commitment to accuracy and sense of urgency
  • Excellent quantitative analytical skills
  • Strong communication and presentation skills, can easily present complex financial issues to non-finance executives (solid PowerPoint skills preferred)
  • Well-versed in financial modeling and budget management, with the ability to identify key variance drivers and create forecasting models to predict the future with accuracy
  • Proficient in using financial software and data analysis tools to manipulate and analyze large datasets.
Responsibilities
  • Collaborate with various departments to understand their financial needs, provide analytical support, and offer insights for informed decision-making.
  • Serve as the key business partner to Discovery and Tech business functions, focusing on providing financial day-to day support for their strategic programs.
  • Plan and carry out budget procedures including monitoring of department expenditures, communicating status to management, reviewing and making recommendations on business unit and department budget proposals.
  • Manage and enhance forecasting models to ensure expense management with a high degree of accuracy.
  • Provide budget vs.actual reporting including variance explanations and commentary and various ad-hoc analyses to support strategic initiatives and business growth.
  • Support the annual budget/LRP processes and consolidations around headcount, opex and capex planning.
  • Work closely with the Accounting team to ensure accurate classification of expenses for management reporting purposes and to provide budget managers with financial and activity based analysis.
  • Proactively identify opportunities for process improvement.
  • Support company Long Range Financial planning process by developing appropriate models and making adjustments over time to optimize the process.
  • Support existing partner collaboration analysis and contribute to business development financial modeling.
  • Build financial models and analyze business development opportunities, risks, synergies and overall cost models.

ArsenalBio focuses on developing programmable cell therapies to treat solid tumor cancers. Their approach involves reprogramming cells to enhance their ability to fight cancer. The company is currently in the clinical stage, concentrating on research and development to bring these therapies to market. Their target clients are patients with solid tumor cancers, a significant segment of the cancer patient population. Unlike many competitors, ArsenalBio emphasizes a diverse team of experts from various scientific and clinical backgrounds, all working towards the common goal of creating effective cancer treatments. Once their therapies receive approval, they plan to generate revenue through sales to healthcare providers.

Company Stage

Series C

Total Funding

$612.8M

Headquarters

San Francisco, California

Founded

2019

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

76%
Simplify Jobs

Simplify's Take

What believers are saying

  • Secured $325 million in Series C funding to advance clinical development.
  • Partnership with Genentech enhances T-cell therapy research and development capabilities.
  • First patient dosed in Phase 1/2 trial for clear-cell renal cell carcinoma treatment.

What critics are saying

  • High manufacturing costs may limit scalability and market competitiveness.
  • Regulatory hurdles for CRISPR therapies could delay clinical trial progress.
  • Dependence on partnerships for manufacturing poses risks if collaborations face issues.

What makes ArsenalBio unique

  • ArsenalBio integrates CRISPR, synthetic biology, and machine learning for advanced cell therapies.
  • Their CITE technology targets tumors while preserving healthy tissues, enhancing treatment safety.
  • ArsenalBio's Integrated Circuit T cells offer a novel approach to overcoming tumor microenvironments.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical, dental, & vision coverage

Virtual & telehealth options

Parental leave

Flexible work schedule

Flexible PTO

Mental health resources